Assessing the relationship between event-free and overall survival in randomized controlled trials of perioperative chemoimmunotherapy in gastroesophageal cancers
Publication date: September 2026 Source: ESMO Gastrointestinal Oncology, Volume 13, Part B Author(s): S.M. Durbin, N. Teeyapun, M.R. Strickland, J. Prince, A. Gupta, H. Park, I. Sahin, H. Zheng, S.J. Klempner
Assessing the relationship between event-free and overall survival in randomized controlled trials of perioperative chemoimmunotherapy in gastroesophageal cancers. // ESMO Gastrointestinal Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949819826000683?dgcid=rss_sd_all
Assessing the relationship between event-free and overall survival in randomized controlled trials of perioperative chemoimmunotherapy in gastroesophageal cancers. ESMO Gastrointestinal Oncology. https://www.sciencedirect.com/science/article/pii/S2949819826000683?dgcid=rss_sd_all
“Assessing the relationship between event-free and overall survival in randomized controlled trials of perioperative chemoimmunotherapy in gastroesophageal cancers.” ESMO Gastrointestinal Oncology.
@article{article44785,
title = {Assessing the relationship between event-free and overall survival in randomized controlled trials of perioperative chemoimmunotherapy in gastroesophageal cancers},
journal = {ESMO Gastrointestinal Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949819826000683?dgcid=rss_sd_all}
}